Patanjali Ayurved Ltd. informed the Supreme Court on Tuesday that it has halted the sale of 14 products whose manufacturing licenses were suspended by the Uttarakhand State Licensing Authority in April.
The company stated before a bench of Justices Hima Kohli and Sandeep Mehta that it has instructed 5,606 franchise stores to withdraw these products.
Additionally, it has directed media platforms to cease advertising these 14 products.
The bench directed Patanjali to file an affidavit within two weeks confirming whether social media intermediaries have complied with the request to remove advertisements and whether all advertisements of the 14 products have been withdrawn. The matter is scheduled for further hearing on July 30.
The Supreme Court is hearing a plea by the Indian Medical Association (IMA) alleging a smear campaign by Patanjali against the COVID-19 vaccination drive and modern medicine. The Uttarakhand State Licensing Authority had previously informed the court that the manufacturing licenses for the 14 products of Patanjali Ayurved Ltd and Divya Pharmacy were “suspended with immediate effect.”
On May 14, the Supreme Court reserved its order on the contempt notice issued to yoga guru Ramdev, his aide Balkrishna, and Patanjali Ayurved Ltd concerning misleading advertisements.
The Supreme Court has upheld a decision by the Madras High Court granting a divorce…
The Delhi High Court has granted transit anticipatory bail to a lawyer whose brother is…
Former Supreme Court Justice Madan B Lokur has been recently named the chairperson of the…
The Karnataka High Court has recently directed the National Law School of India University (NLSIU)…
The Allahabad High Court has directed the Uttar Pradesh Vigilance Department to investigate the Himalayan…
The Allahabad High Court on Friday issued an order staying the arrest of Mohammed Zubair,…